Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. GenSight Biologics S.A.
  6. News
  7. Press Releases
    SIGHT   FR0013183985

GENSIGHT BIOLOGICS S.A.

(SIGHT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société GENSIGHT BIOLOGICS S.A.
05/11GENSIGHT BIOLOGICS S A  : Corporate presentation, May 2021
PU
05/11GENSIGHT BIOLOGICS S A  : Corporate presentation, June 2021
PU
04/30GENSIGHT BIOLOGICS S A  : Compensation Policies
PU
04/09GENSIGHT BIOLOGICS S A  : - focused on developing and commercializing innovative..
AQ
04/08GENSIGHT BIOLOGICS S A  : Nominees to the Board of Directors – 2021 Genera..
PU
04/08GENSIGHT BIOLOGICS S A  : Notice of General Meeting on April 29, 2021
PU
04/08GENSIGHT BIOLOGICS S A  : Annual General Meeting on April 29, 2021
PU
04/07GENSIGHT BIOLOGICS S A  : Corporate presentation, April 2021
PU
03/29GENSIGHT BIOLOGICS S A  : successfully raises EUR30 million in an oversubscribed..
AQ
03/26GENSIGHT BIOLOGICS S A  : launches a reserved offering of c. EUR25 million by me..
AQ
03/26GENSIGHT BIOLOGICS  : Successfully Raises €30 Million in an Oversubscribed Priva..
BU
03/25GENSIGHT BIOLOGICS  : Launches a Reserved Offering of c. €25 Million by Means of..
BU
03/18GENSIGHT BIOLOGICS S A  : Corporate presentation, March 2021
PU
03/10GENSIGHT BIOLOGICS  : Reports Full Year 2020 Financial Results and provides an O..
BU
02/15GENSIGHT BIOLOGICS  : Announces Publication of Results from LUMEVOQ® Phase I/IIa..
BU
02/04GENSIGHT BIOLOGICS S A  : Announces the Publication in Communications Biology of..
PU
02/04GENSIGHT BIOLOGICS  : Announces the Publication in Communications Biology of the..
BU
01/19GENSIGHT BIOLOGICS  : Reports Cash Position as of December 31, 2020 and Provides..
BU
01/18GENSIGHT BIOLOGICS  : Announces its 2021 Financial Calendar
BU
01/18GENSIGHT BIOLOGICS S A  : Corporate presentation, January 2021
PU
01/14GENSIGHT BIOLOGICS S A  : - ESSA Pharma Announces Clinical Collaboration with Ja..
AQ
01/13GENSIGHT BIOLOGICS  : Announces Publication of Results from LUMEVOQ® RESCUE Pivo..
BU
2020GENSIGHT BIOLOGICS S A  : Announces Publication of Results from LUMEVOQ REVERSE ..
AQ
2020GENSIGHT BIOLOGICS  : Announces the Partial Conversion of Convertible Bonds and ..
BU
2020GENSIGHT BIOLOGICS  : Announces Publication of Results from LUMEVOQ® REVERSE Piv..
BU
2020GENSIGHT BIOLOGICS S A  : reports validation of LUMEVOQ Marketing Authorisation ..
AQ
2020GENSIGHT BIOLOGICS S A  : reports validation of LUMEVOQ® Marketing Authorisation..
PU
2020GENSIGHT BIOLOGICS  : Reports Validation of LUMEVOQ® Marketing Authorisation App..
BU
2020GENSIGHT BIOLOGICS S A  : successfully raises EUR25 million in an oversubscribed..
AQ
2020GENSIGHT BIOLOGICS S A  : Securities Note
PU
2020GENSIGHT BIOLOGICS S A  : Amendment to the 2019 Universal Registration Document
PU
2020GENSIGHT BIOLOGICS S A  : launches a capital increase of approximately EUR25 mil..
AQ
2020GENSIGHT BIOLOGICS S A  : successfully raises €25 million in an oversubscribed p..
PU
2020GENSIGHT BIOLOGICS S A  : Successfully Raises €25 Million in an Oversubscribed P..
BU
2020GENSIGHT BIOLOGICS S A  : launches a capital increase of approximately €25 milli..
PU
2020GENSIGHT BIOLOGICS S A  : Reports Cash Position as of September 30, 2020 and Pro..
AQ
2020GENSIGHT BIOLOGICS S A  : Appoints Elsy Boglioli to its Board of Directors
AQ
2020GENSIGHT BIOLOGICS S A  : Reports Cash Position as of September 30, 2020 and Pro..
PU
2020GENSIGHT BIOLOGICS S A  : Reports Cash Position as of September 30, 2020 and Pro..
BU
2020GENSIGHT BIOLOGICS S A  : Appoints Elsy Boglioli to its Board of Directors
PU
2020GENSIGHT BIOLOGICS  : Appoints Elsy Boglioli to Its Board of Directors
BU
2020GENSIGHT BIOLOGICS S A  : Corporate presentation, October 2020
PU
2020GENSIGHT BIOLOGICS S A  : Announces Publication of Meta-Analysis Confirming that..
AQ
2020GENSIGHT BIOLOGICS  : Announces Publication of Meta-Analysis Confirming that Spo..
BU
2020GENSIGHT BIOLOGICS S A  : reports new analysis demonstrating statistically signi..
AQ
2020GENSIGHT BIOLOGICS S A  : Corporate presentation, September 2020
PU
2020GENSIGHT BIOLOGICS S A  : reports new analysis demonstrating statistically signi..
PU
2020GENSIGHT BIOLOGICS  : Reports New Analysis Demonstrating Statistically Significa..
BU
2020GENSIGHT BIOLOGICS S A  : Submits EU Marketing Authorisation Application for LUM..
AQ
2020GENSIGHT BIOLOGICS S A  : Submits EU Marketing Authorisation Application for LUM..
PU
2020GENSIGHT BIOLOGICS S A  : Submits EU Marketing Authorisation Application for LUM..
BU
2020GENSIGHT BIOLOGICS  : Draws Down the €4 Million Second Tranche of Bonds From Kre..
BU
2020GENSIGHT BIOLOGICS S A  : 2020 Half-Year Financial Report
PU
2020GENSIGHT BIOLOGICS S A  : Reports Interim Financial Results for the First Half o..
BU
2020GENSIGHT BIOLOGICS  : Reports Final REALITY Natural History Study Results Confir..
BU
2020GENSIGHT BIOLOGICS S A  : obtains a EUR7m non-dilutive loan and renegotiates the..
AQ
2020GENSIGHT BIOLOGICS  : Obtains a €7m Non-Dilutive Loan and Renegotiates the Bond ..
BU
2020GENSIGHT BIOLOGICS S A  : Corporate presentation, June 2020
PU
2020GENSIGHT BIOLOGICS  : Reports Sustained Efficacy and Safety Among LHON Patients ..
BU
2020GENSIGHT BIOLOGICS  : to Host LUMEVOQ® Key Opinion Leader Call on July 9, 2020
BU
2020GENSIGHT BIOLOGICS  : will hold its General Meeting on April 29, 2020 behind clo..
AQ
2020GENSIGHT BIOLOGICS  : Will Hold Its General Meeting on April 29, 2020 Behind Clo..
BU
2020GENSIGHT BIOLOGICS  : Reports Cash Position as of March 31, 2020 and Provides Op..
BU
2020GENSIGHT BIOLOGICS  : on Track to Submit LUMEVOQ for European Approval in Septem..
AQ
2020GENSIGHT BIOLOGICS  : Announces Positive Data Safety Monitoring Board Review of ..
AQ
2020GENSIGHT BIOLOGICS  : on Track to Submit LUMEVOQ® for European Approval in Septe..
BU
2020GENSIGHT BIOLOGICS  : Announces Positive Data Safety Monitoring Board Review of ..
BU
2020GENSIGHT BIOLOGICS  : Annual General Meeting on April 29, 2020 Procedures for ob..
AQ
2020GENSIGHT BIOLOGICS  : Annual General Meeting on April 29, 2020 Procedures for ob..
PU
2020GENSIGHT BIOLOGICS : Annual General Meeting on April 29, 2020
BU
2020GENSIGHT BIOLOGICS  : Announces the Filing of its 2019 Universal Registration Do..
BU
2020GENSIGHT BIOLOGICS  : Nominees to the Board of Directors
PU
2020GENSIGHT BIOLOGICS  : Explanatory statement
PU
2020GENSIGHT BIOLOGICS  : Provides Update on Operations in the Context of COVID-19
PU
2020GENSIGHT BIOLOGICS  :  GenSight Biologics Provides Update on Operations in the C..
BU
1  2Next
Upcoming event on GENSIGHT BIOLOGICS S.A.
07/29/21